Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001382963-20-000030)

Filing Details

Accession Number:: 0001382963-20-000030
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-13 18:13:30
Reporting Period:: 2020-03-04

Accepted Time:: 2020-03-13 18:13:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1460702	Ritter Pharmaceuticals Inc	RTTR	Pharmaceutical Preparations (2834)	263474527

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1631671	J Andrew Ritter	Ritter Pharmaceuticals, Inc. 1880 Century Park East, Suite 1000 Los Angeles CA 90067	Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-03-04	18,750	$0.38	81,727	No	4	S	Indirect	By Stonehenge Partners LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Stonehenge Partners LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	625	Direct

Footnotes

As a managing partner of Stonehenge Partners LLC, the Reporting Person may be deemed the beneficial owner of these securities. The Reporting Person expressly disclaims beneficial ownership over these securities except to the extent of his pecuniary interest therein.